All G Adds Human Lactoferrin to US Portfolio With Self-Affirmed GRAS Status
Save
Approvals

All G Adds Human Lactoferrin to US Portfolio With Self-Affirmed GRAS Status

Vegconomist • Nov 18, 2026
All G, a biotech company based in Sydney, has self-affirmed the Generally Recognized as Safe (GRAS) status for its recombinant human lactoferrin, produced via precision fermentation. This milestone allows the protein to be used in adult nutrition and supplement products in the United States, making All G the sole provider of both human and bovine lactoferrin on the market. The company’s human lactoferrin is designed to closely match that found in breast milk in terms of specific amino acid clusters and low iron saturation, ensuring its bioactivity and compatibility with human biology.

In internal tests, All G's human lactoferrin demonstrated significantly enhanced antimicrobial and binding capabilities compared to existing commercial variants. The distinct characteristics of human and bovine lactoferrin suggest different applications, with the former targeting women’s health and childhood products, while the latter focuses on immunity and gut health. All G has ambitions to expand its offerings, developing additional human milk proteins that could revolutionize infant formula, aligning with its goal of replicating the complete protein profile of breast milk.
*This summary was generated using AI.
Read Full Article

Related recipes, books, documentaries, and topics from our catalog.

Community reviews

Sign in to leave the first review.

Discussion Join the conversation

Sign in to start the discussion.